NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
49 hedge funds and large institutions have $150M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
20% more funds holding
Funds holding: 41 → 49 (+8)
5% less capital invested
Capital invested by funds: $158M → $150M (-$8.28M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $2.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$27.4M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$6.55M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.17M |
| 4 |
SAM
Senzar Asset Management
New York
|
+$2.84M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$11.4M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$8.67M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.46M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$2.27M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.07M |
NDRM Hedge Fund Activity: Q4 2015 in Review
49 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2015, worth a combined $150M — down 5.2% from $158M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NDRM positions and 13 closed out — a net gain of 8 holders — while 14 added to existing stakes and 11 trimmed.
The largest buyer was Scopia Capital Management, adding an estimated $27.4M. The largest seller was Avoro Capital Advisors, cutting an estimated $11.4M.
- 49 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2015, up from 41 in Q3 2015.
- Funds reported $150M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2015, down 5.2% quarter-over-quarter.
- 21 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2015 and 13 closed out, a net change of +8 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2015 was Scopia Capital Management, an estimated $27.4M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2015 was Avoro Capital Advisors, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2015.